Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Nov;28(11):1474-7.
doi: 10.1136/gut.28.11.1474.

Influence of olsalazine on gastrointestinal transit in ulcerative colitis

S S Rao  1 , N W Read, C D Holdsworth
Affiliations

Influence of olsalazine on gastrointestinal transit in ulcerative colitis

S S Rao et al. Gut. 1987 Nov.

Abstract

The effect of olsalazine on stool output and the transit of a solid radiolabelled meal through the stomach, small intestine and colon was studied in six patients with ulcerative colitis intolerant of sulphasalazine. Olsalazine 250 mg four times daily significantly accelerated gastric emptying (mean +/- SD; 45.3 +/- 24.2 min v 67.3 +/- 33.1 min, p less than 0.05), mouth to caecum transit time (242 +/- 41 min v 325 +/- 33 min, p less than 0.02) and whole gut transit time (60.5 +/- 26 h v 37.8 +/- 17.8 h, p less than 0.05). No significant changes were seen in mean daily stool weight (215 +/- 41 g v 162 +/- 62 g) and mean daily stool frequency (2.2 +/- 0.6 v 2.4 +/- 1.8). None of these patients developed diarrhoea, but acceleration of gastric and intestinal transit may be responsible for the diarrhoea reported in some patients taking this drug.

PubMed Disclaimer

References

    1. Gut. 1980 Jul;21(7):632-5 - PubMed
    1. Gut. 1982 Dec;23(12):1081-7 - PubMed
    1. Gastroenterology. 1980 Dec;79(6):1276-82 - PubMed
    1. Gut. 1983 May;24(5):405-11 - PubMed
    1. Br Med J (Clin Res Ed). 1985 Nov 16;291(6506):1373-5 - PubMed

Publication types